Cardiac Troponin I (TNNI3) (N-Term) Peptide
-
- Target See all TNNI3 products
- TNNI3 (Cardiac Troponin I (TNNI3))
- Protein Region
- N-Term
- Origin
- Human, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- APVRRRSSAN YRAYATEPHA KKKSKISASR KLQLKTLMLQ IAKQEMEREA
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Tnni3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TNNI3 (Cardiac Troponin I (TNNI3))
- Background
-
Tnni3 is a cardiac isoform of troponin I, which is a subunit of the troponin complex, Tnni3 inhibits actomyosin ATPase activity in muscle conraction.
Alias Symbols: TnI, cTNI
Protein Size: 211 - Molecular Weight
- 23 kDa
- Gene ID
- 29248
- NCBI Accession
- NM_017144, NP_058840
- UniProt
- P23693
-